首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   84篇
  免费   1篇
  国内免费   1篇
基础医学   2篇
临床医学   2篇
皮肤病学   1篇
外科学   14篇
综合类   16篇
预防医学   2篇
药学   4篇
中国医学   45篇
  2023年   1篇
  2022年   4篇
  2021年   1篇
  2020年   3篇
  2019年   6篇
  2018年   3篇
  2017年   1篇
  2015年   2篇
  2014年   4篇
  2013年   1篇
  2012年   5篇
  2011年   5篇
  2010年   10篇
  2009年   10篇
  2008年   8篇
  2007年   13篇
  2006年   3篇
  2005年   1篇
  2004年   1篇
  2003年   1篇
  2002年   1篇
  2001年   1篇
  2000年   1篇
排序方式: 共有86条查询结果,搜索用时 20 毫秒
1.
目的:观察补肾活血汤治疗阳痿肾虚血瘀证的临床疗效。方法:将确诊的80例阳痿肾虚血瘀证患者随机分为两组。治疗组40例采用自拟补肾活血汤治疗,对照组40例用复方蚂蚁胶囊治疗。3个疗程后统计对比疗效。结果:治疗组治愈率、总有效率分别为52.5%、77.5%;对照组分别为37.5%、47.5%,两组疗效比较,治疗组优于对照组(P0.05)。两组治疗后IIEF-5评分均较治疗前升高(P0.01);两组治疗后IIEF-5评分比较,治疗组高于对照组,差异有统计学意义(P0.05)。结论:补肾活血汤治疗阳痿肾虚血瘀证有较好疗效。  相似文献   
2.
目的:通过观察和中消胀超微颗粒治疗腹腔镜胆囊切除术后早期肠麻痹的影响,探讨和中消胀颗粒对腹腔镜胆囊切除术后肠道功能恢复的作用.方法:将48例腹腔镜胆囊切除术后肠麻痹的患者随机分为治疗组和对照组.治疗组24例予以和中消胀超微颗粒治疗,对照组24例予以汉森四磨汤口服液治疗,观察两组治疗前后肠鸣音发生时间、肛门排气排便出现时间及两组中医症状量化评分.结果:与对照组比较,治疗组在治疗后肠鸣音恢复时间及肛门排气排便出现时间均明显缩短(P<0.05),治疗组疗效指数优于对照组(P<0.05).结论:和中消胀超微颗粒有助于术后胃肠功能的恢复,对腹腔镜术后肠麻痹有明显改善作用.  相似文献   
3.
目的:观察前列清巴布贴治疗慢性非细菌性前列腺炎的临床疗效。方法:将80例慢性非细菌性前列腺炎患者随机分为治疗组和对照组各40例,治疗组用前列清巴布贴敷脐治疗,对照组用前列安栓塞肛治疗,观察比较两组综合疗效及治疗前后的NIH—CPSI积分。结果:两组综合疗效及治疗后的NIH—CPSI积分比较差异均有统计学意义(P〈0.05)。结论:前列清巴布贴治疗慢性非细菌性前列腺炎疗效显著。  相似文献   
4.
目的:探讨安糖通痹方治疗大鼠糖尿病周围神经病变作用机制.方法:用小剂量链脲佐菌素(STZ)诱导的方法建立2型DPN大鼠模型,选取健康大鼠50只,随机分为正常组、安糖通痹方小剂量组、大剂量组和VitB12组,分别测定造模前后ET水平及NO水平,进行对比分析.结果:造模成功后各用药组血清NO水平明显低于正常组(P<0.05),ET水平明显高于正常组(P<0.05);经治疗后,安糖通痹方大剂量组的大鼠血清NO显著升高(与小剂量组、VitB12组比较,P<0.05),大鼠血浆ET显著降低(与小剂量组、VitB12组比较,P<0.05).结论:安糖通痹方可以升高血清NO水平,降低ET含量,具有对周围神经和血管的保护作用,且大剂量组效果优于小剂量组.  相似文献   
5.
目的:观察前癃通胶囊对大鼠前列腺增生组织的病理形态学影响并探讨其作用机制。方法:采用双侧睾丸摘除和丙酸睾酮注射复制前列腺增生模型,大鼠随机分成正常组、模型组、阳性药组和前癃通胶囊高、中、低剂量组,分别灌胃给药,30天后处死大鼠,称量前列腺湿重、体积,计算前列腺指数;光镜下观察前列腺组织病理学变化,测定腺上皮面积和间质面积;免疫组化方法检测前列腺组织的成纤维细胞生长因子(FGF)和转化生长因子(TGFβ1)表达。结果:前癃通胶囊可明显减轻前列腺湿重,减小前列腺体积,降低前列腺指数,高剂量组作用最为明显;明显改善前列腺病理组织学变化,明显减少腺上皮面积,减少间质面积;前癃通胶囊可明显降低大鼠前列腺组织的FGF和TGFβ1表达水平。结果:前癃通胶囊可明显改善大鼠前列腺增生的病理变化,降低FGF和TGFβ表达是其作用机理之一。  相似文献   
6.
目的:探讨益气生精汤治疗少弱精子症的临床疗效。方法:将确诊的92例少弱精子症患者随机分为两组。治疗组46例采用自拟益气生精汤治疗,对照组46例采用五子衍宗丸治疗。两组均以1个月为1个疗程,3个疗程后观察比较其疗效。结果:治疗组优于对照组,治疗后精子密度,精子活动率均有明显提高,治疗前后差异具有统计学意义(P0.05)。结论:益气生精汤治疗少弱精子症临床疗效显著。  相似文献   
7.
目的:观察三橘荔核汤对CAP/CPPS患者前列腺液MCP-1、PDGF-BB表达的影响。方法:将符合CAP/CPPS(气滞血瘀型)诊断标准的患者70例随机分为治疗组和对照组各35例,治疗组采用三橘荔核汤口服,对照组采用前列腺汤口服,均以10 d为1个疗程,共3个疗程。观察两组患者临床疗效、NIH-CPSI积分及前列腺液中细胞因子MCP-1、PDGF-BB水平的变化。结果:两组治疗后综合疗效比较,差异有统计学意义(P0.05);NIH-CPSI积分比较,差异有统计学意义(P0.05);MCP-1、PDGF-BB的表达,差异均有统计学意义(P0.05)。结论:三橘荔核汤治疗CAP/CPPS患者临床疗效显著,其作用机理可能是通过调控炎症因子MCP-1、PDGF-BB的表达从而达到免疫调节作用。  相似文献   
8.
Objective To investigate the role of inflammatory cytokines in the pathogenesis of chronic non-bacterial prostatitis/chronic pelvic pain syndrome (CAP/CPPS) patients. Methods The 38 cases with CAP/CPPS patients (18 cases of CAP and 20 cases of CPPS) and 20 cases of healthy controls were selected. The differential expressions of 40 kinds of inflammatory cytokines were detec-ted by antibody arrays in prostate fluid. Results The inflammatory cytokines which increased more than 1.5 times expression have been found. There were seven kinds in CAP including monocyte che-moattractant protein (MCP)-1, solution tumor necrosis factor receptor Ⅱ(s TNF R Ⅱ), platelet-de-rived growth faetor-BB (PDGF-BB), interleukin (IL)-β, IL-11、IL-6、MCP-2 and five kinds in CPPS groups including MCP-1、PDGF-BB、MCP-2、s TNF R Ⅱ、It-11 respectively, compared with healthy control group. The cluster analysis results showed that protein expression of Monocyte chemoattrac-tant protein 1 (MCP-1)and platelet-derived growth factor BB (PDGF-BB) were significantly increased in CAP (3.47 and 2.07 times) and CPPS (2.25 and 2.19 times) compared with healthy control group and were the final polymerization of inflammatory cytokines. The protein expression of interleukin 1 β (IL-1 β), MCP-1 and soluble tumor necrosis factor Ⅱ (s TNF R Ⅱ) in CAP group was increased more than 1.85,1.55,1.67 times compared with CPPS group. Conclusions Elevated expression of inflammatory cytokines may play an important role in the course of CAP/CPPS disease. The extent of the inflammatory response of CAP was higher than CPPS. The inflammatory factors of MCP-1 and PDGF-BB could serve as a novel diagnostic marker.  相似文献   
9.
Objective To investigate the role of inflammatory cytokines in the pathogenesis of chronic non-bacterial prostatitis/chronic pelvic pain syndrome (CAP/CPPS) patients. Methods The 38 cases with CAP/CPPS patients (18 cases of CAP and 20 cases of CPPS) and 20 cases of healthy controls were selected. The differential expressions of 40 kinds of inflammatory cytokines were detec-ted by antibody arrays in prostate fluid. Results The inflammatory cytokines which increased more than 1.5 times expression have been found. There were seven kinds in CAP including monocyte che-moattractant protein (MCP)-1, solution tumor necrosis factor receptor Ⅱ(s TNF R Ⅱ), platelet-de-rived growth faetor-BB (PDGF-BB), interleukin (IL)-β, IL-11、IL-6、MCP-2 and five kinds in CPPS groups including MCP-1、PDGF-BB、MCP-2、s TNF R Ⅱ、It-11 respectively, compared with healthy control group. The cluster analysis results showed that protein expression of Monocyte chemoattrac-tant protein 1 (MCP-1)and platelet-derived growth factor BB (PDGF-BB) were significantly increased in CAP (3.47 and 2.07 times) and CPPS (2.25 and 2.19 times) compared with healthy control group and were the final polymerization of inflammatory cytokines. The protein expression of interleukin 1 β (IL-1 β), MCP-1 and soluble tumor necrosis factor Ⅱ (s TNF R Ⅱ) in CAP group was increased more than 1.85,1.55,1.67 times compared with CPPS group. Conclusions Elevated expression of inflammatory cytokines may play an important role in the course of CAP/CPPS disease. The extent of the inflammatory response of CAP was higher than CPPS. The inflammatory factors of MCP-1 and PDGF-BB could serve as a novel diagnostic marker.  相似文献   
10.
最近,30多岁的陈先生查出患了痛风,服用了很多药后发现自己出现勃起功能障碍.痛风会影响男性性功能吗? 1.什么是痛风? 痛风是一种由于嘌呤生物合成代谢增加,尿酸产生过多或因尿酸排泄不良而致血中尿酸升高,尿酸盐结晶沉积在关节滑膜、滑囊、软骨及其他组织中引起的反复发作性炎性疾病.本病以关节液和痛风石中可找到有双折光性的单水尿酸钠结晶为特点.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号